Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer

Australian and New Zealand Journal of Surgery

Volumn 69, Issue 9, 1999, Pages 647-650

  Alagol H ^a   Erdem, E ^a,b   Sancak, B ^b   Turkmen, G ^a   Camlibel, M ^a   Bugdayci, G ^b  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b NONE

Author keywords

Breast cancer; Malondialdehyde; Nitric oxide

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; POLYUNSATURATED FATTY ACID;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID METABOLISM; MACROPHAGE; MAMMOGRAPHY; OXIDATIVE STRESS;

EID: 0032848371     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.1999.01656.x     Document Type: Article

References (19)

1. 1. Knowles R. Nitric oxide synthases. Biochemist. 1994; 3-6.
2. 2. Kiechle FL, Malinski T. Nitric oxide, biochemistry, pathophysiology, and detection. Clin. Chem. 1993; 100: 567-73.
3. 3. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin. Chem. 1995; 41: 892-6.
4. 4. Zaridze DG, Chevehenko VE, Levtshuk AA, Lifanova YE, Maximovitch DM. Fatty acid composition of phospholipids in erythrocyte membranes and risk of breast cancer. Int. J. Cancer 1990; 45: 807-10.
5. 5. Saintot M, Astre C, Pujol H, Gerber M. Tumor progression and oxidant-antioxidant status. Carcinogenesis 1996; 17: 1267-71.
6. 6. Gerber M, Astre C, Segale C et al. Proxidant effect of antioxidant vitamins. Oxidant antioxidant status alterations in cancer patients: Relationship to tumor progression. Symposium 1996; 1: 1201-7.
7. 7. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin. Chem. 1995; 41: 904-7.
8. 8. Green LC, Wagner DA, Glogowski J, Skipper PL, Whisnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 1982; 126: 131-8.
9. 9. Yoshioka T, Kwada K, Shiamada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against elevated oxygen toxicity in the blood. Am. J. Obstet. Gynecol. 1979; 135: 972-6.
10. 10. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 1995; 72: 41-4.
11. 11. MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr. Res. 1993; 34: 222-8.
12. 12. Bani D, Masini E, Bello MG, Bigazze M, Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res. 1995; 55: 5272-5.
13. 13. Hibbs JB, Taintor RR, Vavrin Z et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moncada S, Higgs EA (eds) Nitric Oxide from L-Arginine: A Bioregulatory System: Proceedings of the Symposium on Biological Importance of Nitric Oxide, Amsterdam: Exerpta Medica, 1990; 189-223.
14. 14. Gerber M, Richardson S, Crastes de Paulet P, Crastes de Paulet A, Pujol H. Relationship between vitamin E and poly-unsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer 1989; 64: 2347-53.
15. 15. Slater T, Benedetto C, Burton GW, Cheeseman KH, Ingold KU, Nodest JT. Lipid peroxidation in animal tumors: A disturbance in the control of cell division. In: Thaler-Dao H, Paoletti R, Crastes de Paulet A (eds) Icosanoids and Cancer. New York: Raven Press, 1984; 21-9.
16. 16. Miller AC, Samid D. Tumor resistance to oxidative stress: Association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21 ras isoprenylation. Int. J. Cancer 1995; 60: 249-54.
17. 17. Knekt P. Serum Vitamin E level and risk of female breast cancers. Int. J. Epidemiol. 1988; 17: 281-8.
18. 18. Szent-Gyorgyi A, Egyud LG, McLaughlin JA. Keto aldehydes and cell division. Science 1967; 155: 539-41.
19. 19. Cerutti PA. Response modification in carcinogenesis. Environ. Health Perspect. 1989; 81: 39-43.